L. Siger

472 total citations
16 papers, 345 citations indexed

About

L. Siger is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, L. Siger has authored 16 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Public Health, Environmental and Occupational Health and 4 papers in Epidemiology. Recurrent topics in L. Siger's work include Viral Infections and Vectors (5 papers), Mosquito-borne diseases and control (5 papers) and Viral Infections and Outbreaks Research (4 papers). L. Siger is often cited by papers focused on Viral Infections and Vectors (5 papers), Mosquito-borne diseases and control (5 papers) and Viral Infections and Outbreaks Research (4 papers). L. Siger collaborates with scholars based in United States, France and Austria. L. Siger's co-authors include Richard A. Bowen, Kemal Karaca, J.M. Minke, Paul Gordy, Jean-Christophe Audonnet, Sheena M. Loosmore, Jules Minke, Robert Nordgren, Randall W. Renshaw and C. Breathnach and has published in prestigious journals such as Vaccine, American Journal of Tropical Medicine and Hygiene and American Journal of Veterinary Research.

In The Last Decade

L. Siger

16 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Siger United States	9	223	187	80	60	32	16	345
A. Arenas Spain	14	177 0.8×	139 0.7×	154 1.9×	79 1.3×	39 1.2×	22	379
Kridsada Chaichoun Thailand	10	195 0.9×	128 0.7×	134 1.7×	83 1.4×	41 1.3×	22	394
Masaoki Yamaoka Japan	10	285 1.3×	286 1.5×	131 1.6×	47 0.8×	10 0.3×	16	442
Yoram Weisman Israel	7	248 1.1×	250 1.3×	90 1.1×	17 0.3×	24 0.8×	10	411
Xiao Fang Lim Singapore	11	279 1.3×	78 0.4×	73 0.9×	56 0.9×	29 0.9×	17	373
Eveline Wodak Austria	9	250 1.1×	127 0.7×	186 2.3×	113 1.9×	43 1.3×	13	413
Norimitsu Hosaka Japan	7	128 0.6×	143 0.8×	127 1.6×	20 0.3×	11 0.3×	7	455
M.A. Vissani Argentina	11	189 0.8×	169 0.9×	206 2.6×	127 2.1×	94 2.9×	34	449
Asefa Deressa Ethiopia	10	130 0.6×	124 0.7×	89 1.1×	91 1.5×	25 0.8×	23	383
Elena Goyena Spain	10	110 0.5×	197 1.1×	139 1.7×	49 0.8×	34 1.1×	24	349

Countries citing papers authored by L. Siger

Since Specialization

Citations

This map shows the geographic impact of L. Siger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Siger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Siger more than expected).

Fields of papers citing papers by L. Siger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Siger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Siger. The network helps show where L. Siger may publish in the future.

Co-authorship network of co-authors of L. Siger

This figure shows the co-authorship network connecting the top 25 collaborators of L. Siger. A scholar is included among the top collaborators of L. Siger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Siger. L. Siger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Minke, J.M., L. Siger, Lionel Cupillard, et al.. (2011). Protection provided by a recombinant ALVAC®-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain. Vaccine. 29(28). 4608–4612. 38 indexed citations

Adams, Amanda A., Tracy L. Sturgill, C. Breathnach, et al.. (2010). Humoral and cell-mediated immune responses of old horses following recombinant canarypox virus vaccination and subsequent challenge infection. Veterinary Immunology and Immunopathology. 139(2-4). 128–140. 35 indexed citations

Karaca, Kemal, Edward J. Dubovi, L. Siger, et al.. (2007). Evaluation of the ability of canarypox-vectored equine influenza virus vaccines to induce humoral immune responses against canine influenza viruses in dogs. American Journal of Veterinary Research. 68(2). 208–212. 11 indexed citations

Bowen, Richard A., L. Siger, Jules Minke, et al.. (2006). PATHOGENESIS OF WEST NILE VIRUS INFECTION IN DOGS TREATED WITH GLUCOCORTICOIDS. American Journal of Tropical Medicine and Hygiene. 74(4). 670–673. 17 indexed citations

Siger, L., et al.. (2006). Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.. PubMed. 7(3). 249–56. 3 indexed citations

Karaca, Kemal, Richard A. Bowen, L. Siger, et al.. (2005). Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge. Vaccine. 23(29). 3808–3813. 42 indexed citations

Minke, J.M., L. Siger, Kemal Karaca, et al.. (2004). Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge. PubMed. 221–230. 94 indexed citations

Siger, L., Richard A. Bowen, Kemal Karaca, et al.. (2004). Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses. American Journal of Veterinary Research. 65(11). 1459–1462. 46 indexed citations

Woolums, Amelia R., L. Siger, Scott K. Johnson, G. Gallo, & Jennifer Conlon. (2003). Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production. Vaccine. 21(11-12). 1158–1164. 21 indexed citations

10.

Siger, L., et al.. (2001). Kinetics and type of immune response following intranasal and subcutaneous immunisation of calves. Research in Veterinary Science. 71(1). 9–15. 13 indexed citations

11.

Siger, L., et al.. (2000). Efficacy of a BVD Type I MLV Vaccine Against a Virulent BVD Type II Experimental Challenge in Young Calves. American Association of Bovine Practitioners Conference Proceedings. 189–189. 1 indexed citations

12.

Suckow, Mark A., Kinam Park, L. Siger, et al.. (2000). Immunogenicity of antigens in boiled alginate microspheres. Journal of Biomaterials Science Polymer Edition. 11(1). 55–68. 4 indexed citations

13.

Siger, L., et al.. (1998). Tracheal stenosis and collapse in horses. Compendium on Continuing Education for The Practicing Veterinarian. 8 indexed citations

14.

Siger, L., et al.. (1997). Nasal bone deformity associated with inappropriate halter use: A review of two cases. Equine Veterinary Education. 9(5). 228–229. 1 indexed citations

15.

Siger, L., et al.. (1991). Acute lymphocytic leukemia and pseudohyperkalemia in a Jacob ram.. PubMed. 32(8). 498–9. 4 indexed citations

16.

Siger, L., et al.. (1989). Equine rabies with a prolonged course.. Equine practice. 11(1). 6–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact